List of presentations and access to them is restricted to:

TTS Members in good-standing

nKOL - Sweden 2009

Pioneer in Transplantation
Dr. Erna Möller, Knut and Alice Wallenberg Foundation, Stockholm, Sweden

Video Title

Cell Transplantation: From Experiment to Clinical Reality
Chairs:
Michael Olausson, Sweden and Suchitra Sumitran-Holgersson, Sweden


1.1 Experimental and Xeno
KOL  Olle Korsgren, Uppsala Universitet, Uppsala, Sweden
nKOL
Dr. Peetra Magnusson, Sweden

1.2 Basic Science and Experimental Work
KOL Suchitra Sumitran-Holgersson, Sahlgrenka University Hospital, Göteborg, Sweden
nKOL  Dr. Meghnad G. Joshi, Sweden

1.3 MARS Treatment and Its Possible Mechanisms and Effect as Live
Support Therapy in Clinical Settings
KOL  Helena Isoniemi, Helsinki University Hospital, Helsinki, Finland
nKOL Dr. Taru Kantola, Finland

Immunosuppression: Tailoring the Individual Patient
Chairs:
Henrik Ekberg, Sweden and Andreas Tzakis, USA


2.1 Clinical Studies
KOL Henrik Ekberg, Lund University Hospital, Malmö, Sweden
nKOL Dr. Clara Påhlman, Sweden

2.2 The Genetic Way
KOL

Ian Hutchinson, University of Southern California, CA, USA

nKOL

Dr. Steve Horvath, University of California in Los Angeles, CA, USA

2.3 Tolerance Protocols
KOL David H. Sachs, Massachusetts General Hospital, MA, USA
nKOL vid Dr. Tatsuo Kawai, USA


Living Donors: Expanding the Donor Pool
Chairs: Carl Groth, Sweden and Gerhard Opelz, Germany

Co-Chair Comments on "Living Donors: Expanding the Donor Pool:
Carl Groth, Sweden

3.1 Living Donor Nephrectomy: minimizing surgery-maximizing safety
KOL Jonas Wadström, Oslo University Hospital, Oslo, Norway
nKOL

Dr. Alireza Biglarnia, Uppsala, Sweden


3.2 Clinical Setting and Approach to the Patients Family
KOL Anders Hartmann, Rikshospitalet University Hospital, Oslo, Norway
nKOL Dr. Geir Mjøen, Norway

3.3 The Anonymous Donor
KOL Ingela Fehrman Ekholm, Sahlgrenska University Hospital, Göteborg, Sweden
nKOL vid Dr. Annette Lennerling, Sweden

ABO Antibodies: Overcoming the Barriers
Chairs:
Gunnar Tydén, Sweden and Ian V. Hutchinson, USA

4.1

Breaking the ABO Barrier in Kidney Transplantation

KOL Gunnar Tydén, Karolinska University Hospital Huddinge, Stockholm, Sweden
nKOL Dr. Helena Genberg, Sweden

4.2 Liver Transplantation against Blood Groups
KOL  Piotr Kaliciński, Children’s Memorial Health Institute, Poland
nKOL Dr. Malgorzata Markiewicz-Kijewska, Poland

4.3 Experience with ABO Incompatible Kidney Transplants
KOL vid Kazunari Tanabe, Tokyo Women's Medical University, Japan
nKOL vid Dr. Daisuke Tokita, Japan

4.4 Specific Absorption Techniques of ABO Antibodies
KOL vid

Jan Holgersson, Karolinska Institutet, Stockholm, Sweden

nKOL Dr. Linda Björnström, AbSorber AB, Huddinge, Sweden

HLA: Antibodies – Overcoming the Barriers
Chairs:
Gerhard Opelz, Germany and David Sachs, USA

5.1 An Integrated Approach to Transplantation of Sensitized Patients
KOL Gerhard Opelz, University of Heidelberg, Heidelberg, Germany
nKOL Dr. Caner Süsal, Germany

5.2 The Protective Role of the Liver in Sensitized Patients with Renal
KOL vid Michael Olausson, The Transplant Institute at Sahlgrenska University Hospital, Göteborg, Sweden
nKOL vid Dr. Madeleine Ingelsten, Sweden

5.3

Live Donor Exchange Program of New England

KOL

Francis L. Delmonico, New England Organ Bank, MA, USA

nKOL Dr. Ruthanne Hanto, USA

Composite Transplant Allografts – the new challenges
Chairs:
Jean-Michel Dubernard, France and Søren Schwartz Sørensen, Denmark

6.1

Long Term Follow Up of Composite Tissue Allografts: Is there any evidence of chronic rejection in CTA

KOL

Jean-Michel Dubernard, Hôpital Édouard Herriot, Lyon, France

nKOL Dr. Lionel Badet, France

6.2 Innovative Procedures in Pediatric Intestinal Failure and Transplantation
KOL
Andreas Tzakis, University of Miami, FL, USA
nKOL

Dr Eddie Island, USA


6.3 Uterus Transplantation
KOL Mats Brännström, Sahlgrenska University Hospital, Göteborg, Sweden
nKOL Dr. Caiza Wranning, Sweden

Public Policy Issues
Chairs:
Francis L. Delmonico, USA and Annika Tibell, Sweden


7.1 The Development of the Liver Registry in the PRC
KOL

Sheung-Tat Fan, The University of Hong Kong, People’s Republic of China

nKOL Dr. Haibo Wang, People’s Republic of China

7.2 Latin American Transplantation Update
KOL Mario Uribe, Servicio de Cirugía Hospital del Salvador, Chile
nKOL Dr. Gloria Gonzalez, Chile

7.3 Live Donor Experience in Pakistan
KOL

Syed Adibul Hasan Rizvi, Sindh Institute of Urology & Transplantation, Pakistan

nKOL Dr. Tahir Aziz, Pakistan